Four neuropeptides that inhibit juvenile hormone synthesis by the corpora allata have been isolated from brains of the virgin female cockroach Diploptera punctata. These allatostatins are 8-13 amino acids long, are amidated, and show sequence similarity, including a 3-amino acid sequence at the C-terminal end that is common to all four peptides. The peptide sequences are as follows: allatostatin 1, Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-
The regulation of endocrine organs by neuropeptides from the brain is strikingly similar in organisms as different as vertebrates and insects (1) . For example, in vertebrates, neuropeptides produced by the hypothalamus of the brain regulate a major endocrine gland, the anterior pituitary (2) . Directly parallel to this in insects is the regulation ofthe major endocrine organs, the corpora allata (CA) and the prothoracic glands, by neuropeptides produced by the pars intercerebralis and pars lateralis of the brain (3) . Great advances have been made in isolating and characterizing neuropeptides that regulate endocrine glands in vertebrates (4, 5) . Far less attention has been directed toward analysis of the analogous neuropeptides in insects (6) , although insect systems because of their relative simplicity are advantageous for studying the mechanisms of this basic neuroendocrine relationship (1) .
Recent progress has been made in establishing the structures of the prothoracicotropic hormones, neuropeptides that stimulate the prothoracic gland to produce the growth hormones, ecdysteroids. In the lepidopterans Bombyx mori and Manduca sexta, these appear to occur as large and small peptides and within these size groups in multiple forms (7) (8) (9) . Although the primary structures of the two peptides in M. sexta are not yet known, both have prothoracicotropic activity in this species (7) . In B. mori the primary structure of the small peptide, which resembles insulin, and part of the large peptide are known, but only the large peptide is active in this species (8, 9) .
We are concerned here with the brain-CA axis. The sole known product of the endocrine cells of the CA is juvenile hormone (JH), in one or several forms depending on the species of insect (10) . The modulated synthesis of JH is, in most species, required not only for development in immature stages but also for reproduction in the adult stage, especially for vitellogenesis in the female (3, 11) . Peptidergic neurosecretory material from cells of the brain that project to the CA have long been postulated to regulate the activity of the CA, either as stimulators, allatotropins (e.g., refs. 12-16), or inhibitors, allatostatins (e.g., refs. [17] [18] [19] [20] [21] . Experimental evidence suggests that one of these effects may predominate depending upon the species (10) .
A pioneering investigation on neurosecretion in the brain of the cockroach Leucophaea maderae revealed that the CA were released from inhibition when the nerve tract from the brain to the CA was severed (22) . Until recently little progress has been made toward isolating either allatotropins or allatostatins. An allatotropin has been isolated from heads ofM. sexta and its primary structure has been elucidated (23) ; as yet no primary structure for an allatostatin is known. However, brain extract has been shown for several species of insects to inhibit JH synthesis (19, 24) . Extract of brains from the cockroach Diploptera punctata contains peptidergic material that inhibits JH synthesis by the CA in vitro (19, 25, 26) . In this paper we describe the isolation and primary structure of allatostatins extracted from brains ofadult virgin female D. punctata. The activity of these native and synthetic allatostatins was tested on CA in vitro. In addition, the reversibility and the stage and species specificity of synthetic allatostatins were tested.
MATERIALS AND METHODS Animals. The viviparous cockroach D. punctata was maintained and staged females were obtained as described (27, 28) . Adult Periplaneta americana females were removed from stock cultures on the day of emergence and maintained at 270C.
CA of virgin D. punctata females do not undergo cycles in JH synthesis but rather are maintained at a relatively constant low rate of synthesis (29) . Brains of virgin females were found to be a good source of allatostatins and their CA responded reproducibly to treatment with brain extract (19, 25) . Therefore, in this investigation we have continued to use the brains of virgin females as a source of allatostatins and their CA to test for allatostatic activity.
Bioassay for Allatostatic Activity. The CA of D. punctata produce only JH III (30) . Rates of JH synthesis by CA were determined by the in vitro radiochemical method of Feyereisen and Tobe (31) as modified by Tobe and Clarke (32 radiolabeled hormone released into the medium. CA were incubated in 50 1.l of radiolabeled medium for 3 hr to establish the normal rate of synthesis; then the glands were transferred to medium containing putative allatostatins or control solutions for a second 3-hr incubation. The percentage change in JH synthesis, [1 -(treated rate/normal rate)] x 100, was calculated. Routinely, one treatment solution was tested on four or five individual glands or pairs of glands; the means of these percentages were used to indicate whether the CA were inhibited as a result of treatment. For screening high-pressure liquid chromatography (HPLC) fractions, any mean inhibition >30% was considered to indicate allatostatic activity since control glands sometimes showed up to 30% change.
Single CA from 2-day virgin females were used to test HPLC fractions for allatostatic activity, to establish doseresponses for inhibition of JH synthesis, and to test reversibility of inhibition of JH synthesis by synthetic peptides. Synthetic allatostatins were also tested on single CA of mated D. punctata and on pairs of CA from D. punctata larvae and P. americana adults.
Brain Extract. Brains were dissected from heads of virgin females (adult age, 2-30 days). Optic lobes and adhering fat body and tracheae were removed. Twenty to 30 brains were homogenized in 0.9% NaCl (10 Al per brain) in a small glass homogenizer. The homogenate was heated to 100'C for 5-10 min and centrifuged at 4000 x g for 20 min, and the supernatant was stored (up to a month) at -80'C until sufficient extract was collected. Pilot separations were run on 50-450 brain equivalents of extract. The final purification was accomplished with extract from 1000-1200 brains.
Purification of Aliatostatins. 1. SEP-PAK preparation of sample. Reverse-phase C18 cartridges (Waters) were prewashed with 5 ml each of 0.1% bovine serum albumin (fraction V, Sigma) with 0.1% trifluoroacetic acid (TFA), 40% acetonitrile (ACN) with 0.1% TFA, and 0.1% aqueous TFA. Extract of 125 brains was loaded (about 3 ,tg of protein per brain equivalent) and reapplied three times. The cartridge was washed with 5 ml each of 0.1% TFA and 17% ACN with 0.1% TFA, and material was eluted with 3 ml of 40% ACN with 0.1% TFA. Protein was not detected in the eluate after loading three times or in the washes. About 1 gg of protein per brain equivalent was removed with the 40% ACN. Allatostatic activity was found in the 40% ACN eluate.
2. First HPLC separation. The 40% ACN eluate of 250 brain equivalents from step 1 was reduced in volume with nitrogen to 200 ,l, diluted to 1 ml with 0.1% TFA, and injected onto a 3.9 mm x 30 cm reverse-phase C18 column (10-,um particle size, ,uBondapak, Waters). HPLC was performed on a Waters system with an automated gradient controller and a model 490 detector. Solvent A was 0.1% TFA in water; solvent B was ACN with 0.1% TFA. A linear gradient from 0% to 50% ACN (1%/min) with a flow rate of 1.5 ml/min was used. Compounds eluting from the column were detected by their absorbance at 220 and 280 nm. Fractions were collected at 1-min intervals. Allatostatic activity was assayed in fractions 10-60 and was limited to fractions between 33 and 42, eluting with 22-31% ACN. A mixture of known peptides {0.5 ,ug each of thyrotropinreleasing hormone, [Lys8]vasopressin, luteinizing hormonereleasing hormone, somatostatin-14, bovine serum albumin (V), and glucagon; all from Sigma} was also separated by this gradient system. Luteinizing hormone-releasing hormone and somatostatin eluted in fractions 33 and 41 or 42, respectively, and therefore these peptides were subsequently used for standard runs to mark the retention time of fractions with allatostatic activity.
3. Second HPLC separation. Five hundred brain equivalents offraction 36 or 37 (the active fractions) from step 2 was reduced in volume, diluted, and injected onto the C18 column as before. A shallower linear gradient, 10-35% ACN over 50 min, with a flow rate of 1 ml/min was used. The regions absorbing at 220 nm were collected by hand into separate tubes and assayed for allatostatic activity. 4 . Third HPLC separation. Purification to apparent homogeneity was achieved by separation of active regions from 1000 brain equivalents of the material from step 3. The material was reduced in volume, diluted as before, and injected onto a reverse-phase 4.5 mm x 15 cm C8 column (5-jim particle size, Jones Chromatography, Littleton, CO).
A linear gradient from 11% to 44% ACN over 50 min with a flow rate of 1 ml/min was used. The UV absorbing peaks were again collected by hand into separate tubes. Each peak was assayed for allatostatic activity.
Storage and Preparation of Eluates for Bioassay. Eluates in ACN (with 0.1% TFA) from the chromatographic separations were stored at -800C until assay or further analysis. For assay aliquots were transferred to 1.5-ml tubes containing 10 ,ul of 0.1% bovine serum albumin and dried with nitrogen.
The material was resuspended in 10 tions [33] [34] [35] [36] [37] [38] [39] [40] [41] . Assays of pooled fractions 33-35, 36-38, and 39-41 using 4.5 brain equivalents per CA showed >50% inhibition of JH synthesis in the three groups. However, only the material in pooled fraction [36] [37] [38] showed >50%o inhibition when tested at 1 brain equivalent per CA. Subsequent separations were limited to this group, specifically fractions 36 and 37. Following the second C18 column separation, active fractions were isolated from both fractions 36 and 37 (first fractionation). Chromatography on a C8 column (third fractionation) separated the active material to apparent homogeneity. Four peaks showed allatostatic activity: one in material derived from fraction 36 and three in material derived from fraction 37 ( Fig. 1 A and B) . All but the first peak derived from fraction 37 (allatostatin 3) showed >50%o inhibition of JH synthesis when tested at 5 brain equivalents per Amino Acid Sequences. Extracts of 1000 and 1200 brains, purified through three HPLC separations, each provided about 100 pmol of material from each ofthe four active peaks.
The amino acid sequences for the four peptides determined by Edman degradation and mass spectral analysis are shown in Fig. 2 . Mass spectral analysis showed that the C terminus was amidated in allatostatins 1, 3, and 4 (allatostatin 2 was not analyzed, but amidation is inferred because this form of the synthetic peptide is bioactive). Values for mass determined by spectrometry were: allatostatin 1, 1335.7; allatostatin 3, 899.5; and allatostatin 4, 969.5. These values match precisely the calculated molecular weights. The collision-induced decomposition tandem mass spectrum for allatostatin 4 was consistent with the sequence determined by Edman degradation (in addition, the collision spectrum showed that the tyrosine was unmodified).
Synthetic Allatostatins. All four allatostatins were synthesized with amidated C termini. In sequential HPLC runs, the elution time of the synthetic allatostatins was the same as that of the native material. The dose-responses for inhibition of JH synthesis for allatostatins 1-4 and the mean and range of control values are shown in Fig. 3 . Inhibition of JH synthesis >40o was achieved with 10-9 M allatostatin 1, 10-8 M allatostatins 2 and 4, and 7 x 10-7 M allatostatin 3.
Reversibility of Inhibition. Allatostatins 1-4 were tested for reversibility of inhibition on CA of 2-day-old virgin females. After treatment with allatostatin, glands were transferred to medium without allatostatin for a third 3-hr incubation.
Results for allatostatins 1 and 2 are shown in Fig. 4 . Data for allatostatins 3 and 4 are not shown. However, for all four allatostatins rates of JH synthesis decreased 60-74% with allatostatin treatment. Rates of JH synthesis increased in the third incubation period and were not significantly different from rates in the first incubation period (Mann-Whitney test). Inhibition of CA of Mated and Larval Females. The effects of synthetic allatostatins on CA of physiological stages other than 2-day adult virgins were also determined. Allatostatin 1 (10-8 M) was tested on CA from 6-day-old mated females, known on the basis of physiological age (the end of the vitellogenic cycle) to show declining rates of JH-synthesis. During the first 3-hr period (untreated), the mean rate of JH synthesis (±SEM) was 10.3 ± 1.5 pmol hr-1 per gland; during the second 3-hr period (treated), the mean rate was 2.4 ± 0.3 pmol hr-1 per gland: an inhibition of 77% (n = 13). The mean rate of JH synthesis of control glands (n = 4) decreased 10% during the corresponding time period.
Species Specificity. Allatostatin 1 (10-8 M) inhibited JH synthesis by CA of adult female P. americana 2-5 days old. The mean untreated rate of JH synthesis (±SEM) was 2.5 ± 0.5 pmol hr-1 per gland; the mean treated rate was 0.2 ± 0.1 pmol hr-1 per gland: an inhibition of 92% (n = 9). The mean g-Leu-Tyr -Gly-Phe-Gly-Leu-NH2
Gly-Asp-Gly-Arg-Leu-Tyr-Ala -Ph. rate of JH synthesis in control glands (n = 9) decreased 5% during the second incubation period.
Computer Search for Similar Peptides. No peptides similar to allatostatins 1-4 were found in either data base. Limited sequence similarity was observed with internal sequences of several animal proteins including cytochrome P-450 reductase (60% similarity for 10 C-terminal amino acids of allatostatin 1) and thyroglobulin precursor (100% similarity for 6 C-terminal amino acids of allatostatin 2).
DISCUSSION
The four allatostatic neuropeptides isolated from the brain of D. punctata inhibit the synthesis of JH by CA in vitro and thus are analogous to the somatostatic neuropeptide of vertebrates that inhibits secretion of somatotropin by the anterior pituitary gland (35) . In fact, somatostatin has been shown to modulate JH synthesis in Blattella germanica, but indirectly, via the brain (36) . The allatostatins are amidated peptides of 8-13 amino acids with considerable structural similarity. The three C-terminal amino acids and the fifth and sixth amino acids from the C terminus are identical in the four peptides, and variability occurs at the N terminus. The sequence differences in the peptides indicate that the smaller peptides are not products of the largest one (Fig. 2) . Thus these allatostatins comprise a family of peptides. They are not similar to any known peptides, but the similarity among the allatostatins at the C terminus is reminiscent of the family of neuropeptides related to FMRFamide (Phe-Met-Arg-Phe-NH2) that has been described by gene isolation in Drosophila (37) . Other families of neuropeptides in invertebrates are, for example, in insects, adipokinetic hormones (38) and leucokinins (39, 40) , and in molluscs, Aplysia egg-laying hormones (41). It will be instructive to determine whether the other fractions of brain extract, which have allatostatic activity but are as yet unidentified, contain additional members of the same family or unrelated peptides.
Inhibition of JH synthesis was achieved with 10-9 M allatostatin 1, 10-8 M allatostatins 2 and 4, and 7 x 10-7 M allatostatin 3 (Fig. 3 ). These differences in activity may be accounted for by the variability in structure at the N terminus (Fig. 2) . Inhibition was completely reversible-i.e., JH rates were restored to pretreatment levels after glands were transferred to normal medium.
Although allatostatin 1 has been isolated from virgin female brains, its activity does not appear to be stage-or speciesspecific. Allatostatin 1 not only inhibits JH synthesis by CA of virgin females but also CA of mated females at the end of vitellogenesis, larval CA, and CA of adult P. americana females. Since allatostatins 2-4 have not been tested on these groups, it is not known how general is their ability to inhibit JH synthesis. Nor is it known whether there is synergistic activity of these forms.
The allatotropin isolated from brains of the lepidopteran, M. sexta, is a peptide of 13 amino acids; its stimulatory effect on CA in vitro appears to be stage-specific and limited to lepidopterans (23) . Its amino acid sequence is not similar to the four allatostatins that we have isolated.
The regulation of the production of JH, one of the major hormones regulating development and reproduction in insects, is a complex process (10) . Identification of allatostatins now provides the molecules that can be used experimentally to extend our understanding of the regulation of JH synthesis at the cellular and organ level. In addition, the availability of Proc. Natl. Acad. Sci. USA 86 (1989) allatostatins will facilitate studies on the regulatory mechanisms of their production and release.
